Search research articles
Contact Us
Filters
Showing results (71-80 of 565) with videos related to
Page
of 57
Sort By:
Current Opinion in Oncology
|
October 11, 2019
Novel molecular targets for the treatment of lung cancer
Rafael Rosell, Niki Karachaliou, Oscar Arrieta
Clinical Lung Cancer
|
March 18, 2009
Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non-Small-Cell Lung Cancer
Rafael Rosell, Jia Wei, Miquel Taron
Expert Review of Respiratory Medicine
|
February 6, 2015
Alectinib: a selective, next-generation ALK inhibitor for treatment of ALK-rearranged non-small-cell lung cancer
Mariacarmela Santarpia, Giuseppe Altavilla, Rafael Rosell
Translational Lung Cancer Research
|
March 26, 2015
The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung
Niki Karachaliou, Rafael Rosell, Santiago Viteri
Expert Opinion on Emerging Drugs
|
September 19, 2007
Emerging drugs for non-small-cell lung cancer
Enriqueta Felip, Mariacarmela Santarpia, Rafael Rosell
The New England Journal of Medicine
|
December 15, 2006
DNA repair by ERCC1 in non-small-cell lung cancer
Fabiana Cecere, Emilio Bria, Rafael Rosell
Translational Lung Cancer Research
|
March 10, 2016
Cancer stem cells in small cell lung cancer
Jordi Codony-Servat, Alberto Verlicchi, Rafael Rosell
Cancer Management and Research
|
December 29, 2010
Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer
Noemí Reguart, Andrés Felipe Cardona, Rafael Rosell
Translational Lung Cancer Research
|
September 22, 2016
Unraveling the genomic complexity of small cell lung cancer
Niki Karachaliou, Aaron E Sosa, Rafael Rosell
Lung Cancer (Amsterdam, Netherlands)
|
October 11, 2007
How could pharmacogenomics help improve patient survival?
Rafael Rosell, Enriqueta Felip, Luis Paz-Ares
Page
of 57
Search research articles
Search
Showing results (71-80 of 565) with videos related to
Sort By:
Page
of 57
Current Opinion in Oncology
|
October 11, 2019
Novel molecular targets for the treatment of lung cancer
Rafael Rosell, Niki Karachaliou, Oscar Arrieta
Clinical Lung Cancer
|
March 18, 2009
Circulating MicroRNA Signatures of Tumor-Derived Exosomes for Early Diagnosis of Non-Small-Cell Lung Cancer
Rafael Rosell, Jia Wei, Miquel Taron
Expert Review of Respiratory Medicine
|
February 6, 2015
Alectinib: a selective, next-generation ALK inhibitor for treatment of ALK-rearranged non-small-cell lung cancer
Mariacarmela Santarpia, Giuseppe Altavilla, Rafael Rosell
Translational Lung Cancer Research
|
March 26, 2015
The role of SOX2 in small cell lung cancer, lung adenocarcinoma and squamous cell carcinoma of the lung
Niki Karachaliou, Rafael Rosell, Santiago Viteri
Expert Opinion on Emerging Drugs
|
September 19, 2007
Emerging drugs for non-small-cell lung cancer
Enriqueta Felip, Mariacarmela Santarpia, Rafael Rosell
The New England Journal of Medicine
|
December 15, 2006
DNA repair by ERCC1 in non-small-cell lung cancer
Fabiana Cecere, Emilio Bria, Rafael Rosell
Translational Lung Cancer Research
|
March 10, 2016
Cancer stem cells in small cell lung cancer
Jordi Codony-Servat, Alberto Verlicchi, Rafael Rosell
Cancer Management and Research
|
December 29, 2010
Role of erlotinib in first-line and maintenance treatment of advanced non-small-cell lung cancer
Noemí Reguart, Andrés Felipe Cardona, Rafael Rosell
Translational Lung Cancer Research
|
September 22, 2016
Unraveling the genomic complexity of small cell lung cancer
Niki Karachaliou, Aaron E Sosa, Rafael Rosell
Lung Cancer (Amsterdam, Netherlands)
|
October 11, 2007
How could pharmacogenomics help improve patient survival?
Rafael Rosell, Enriqueta Felip, Luis Paz-Ares
Page
of 57